NHS National Framework for Transition products commencing 1 October 2024

Award

Description

Project title:  NHS National Framework for Transition products commencing 1 October 2024
Offer reference number: CM/TNS/24/5712
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
 
CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
Lot 1   CESW: 01/10/2024 to 30/09/2025 (12 months) 
Lot 2   NWLN: 01/10/2024 to 30/09/2025 (12 months) 
Lot 3  LSNE: 01/10/2024 to 31/05/2026 (20 months) 

CM/TNS/24/5712/02 - Imatinib
Lot 1  DSW: 01/10/2024 to 30/09/2025 (12 months) 

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete